
|Articles|October 9, 2006
R.Ph.s can help reduce incidence of induced labor
Through-the-roof liability costs are convincing many hospitals to take measures to limit induced labor and the use of associated drugs, particularly the hormone oxytocin. "Inducing labor before 39 weeks places both mother and child at increased risk," said Kathy Connolly, assistant VP of risk management at Premier Inc., an alliance of 1,500 nonprofit hospitals.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating Compounding Peptides and GLP-1s Through Regulations
2
Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action
3
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
4
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
5


























